Join the DDA or

Four Tier 2 medicine supply notices issued

Supply problems lasting until January

October 3rd 2022

Tagged: supply shortages

By Ailsa Colquhoun

Tier 2 medicine supply notifications have been issued for the following items:

  • Nafarelin (Synarel) 200microgram/dose nasal spray
  • Dioralyte oral rehydration sachets
  • Semaglutide (Ozempic) 1mg/0.74ml solution for injection 3ml pre-filled disposable device
  • Dulaglutide (Trulicity) 0.75mg, 1.5mg, 3mg and 4.5mg solution for injection devices

Medicine

Out of stock

Alternatives

Nafarelin (Synarel) 200microgram/dose nasal spray

Until late-December 2022

  • Alternative gonadotrophin-releasing hormone (GnRH) analogues (parenteral formulations) remain available
  • Unlicensed imports
  • See MSN

Dioralyte oral rehydration sachets

Limited resupplies are expected late- December 2022

  • O.R.S Hydration tablets
  • St Mark’s solution
  • Kidderminster formula
  • See MSN

Semaglutide (Ozempic) 1mg/0.74ml solution for injection 3ml pre-filled disposable device

Until week commencing 17 October 2022.Therafter, supply will only be available for existing patients until January 2023

  • Alternate strengths of Semaglutide (Ozempic) remain available but can only support a partial uplift in demand.
  • Alternative GLP-1 receptor agonists (RAs) also remain available
  • See MSN

Dulaglutide (Trulicity) 0.75mg, 1.5mg, 3mg and 4.5mg solution for injection devices

Supplies of dulaglutide (Trulicity) 0.75mg, 1.5mg, 3mg and 4.5mg solution for injection devices are limited until January 2023, supply will only be available for existing patients

  • Supplies of alternative glucagon-like peptide-1 agonists (GLP-1) remain available.
  • See MSN

For up-to-date information on medicines supply issues use the online Medicines Supply Tool (register with SPS).